These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

607 related articles for article (PubMed ID: 21459044)

  • 21. HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis.
    Zivadinov R; Uxa L; Bratina A; Bosco A; Srinivasaraghavan B; Minagar A; Ukmar M; Benedetto Sy; Zorzon M
    Int Rev Neurobiol; 2007; 79():521-35. PubMed ID: 17531857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contributions of vitamin D response elements and HLA promoters to multiple sclerosis risk.
    Nolan D; Castley A; Tschochner M; James I; Qiu W; Sayer D; Christiansen FT; Witt C; Mastaglia F; Carroll W; Kermode A
    Neurology; 2012 Aug; 79(6):538-46. PubMed ID: 22786591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HLA-DRB115 and cerebrospinal-fluid-specific oligoclonal immunoglobulin G bands lower age at attainment of important disease milestones in multiple sclerosis.
    Imrell K; Greiner E; Hillert J; Masterman T
    J Neuroimmunol; 2009 May; 210(1-2):128-30. PubMed ID: 19327846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Latitude and HLA-DRB1 alleles independently affect the emergence of cerebrospinal fluid IgG abnormality in multiple sclerosis.
    Niino M; Sato S; Fukazawa T; Yoshimura S; Hisahara S; Matsushita T; Isobe N; Yoshida K; Houzen H; Miyazaki Y; Shimohama S; Kikuchi S; Kira J
    Mult Scler; 2015 Aug; 21(9):1112-20. PubMed ID: 25583844
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of infectious mononucleosis and HLA-DRB1*15 in multiple sclerosis.
    Nielsen TR; Rostgaard K; Askling J; Steffensen R; Oturai A; Jersild C; Koch-Henriksen N; Sørensen PS; Hjalgrim H
    Mult Scler; 2009 Apr; 15(4):431-6. PubMed ID: 19153174
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HLA-DRB1 allele heterogeneity influences multiple sclerosis severity as well as risk in Western Australia.
    Wu JS; James I; Qiu W; Castley A; Christiansen FT; Carroll WM; Mastaglia FL; Kermode AG
    J Neuroimmunol; 2010 Feb; 219(1-2):109-13. PubMed ID: 20006387
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of multiple sclerosis after a first demyelinating syndrome in an Australian Paediatric cohort: clinical, radiological features and application of the McDonald 2010 MRI criteria.
    Tantsis EM; Prelog K; Brilot F; Dale RC
    Mult Scler; 2013 Nov; 19(13):1749-59. PubMed ID: 23579092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Latitude and HLA-DRB1*04:05 independently influence disease severity in Japanese multiple sclerosis: a cross-sectional study.
    Nakamura Y; Matsushita T; Sato S; Niino M; Fukazawa T; Yoshimura S; Hisahara S; Isobe N; Shimohama S; Watanabe M; Yoshida K; Houzen H; Miyazaki Y; Yamasaki R; Kikuchi S; Kira J;
    J Neuroinflammation; 2016 Sep; 13(1):239. PubMed ID: 27599848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epistasis between HLA-DRB1 parental alleles in a Spanish cohort with multiple sclerosis.
    Romero-Pinel L; Pujal JM; Martínez-Yélamos S; Gubieras L; Matas E; Bau L; Torrabadella M; Azqueta C; Arbizu T
    J Neurol Sci; 2010 Nov; 298(1-2):96-100. PubMed ID: 20810130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vitamin D, HLA-DRB1 and Epstein-Barr virus antibody levels in a prospective cohort of multiple sclerosis patients.
    Wergeland S; Myhr KM; Løken-Amsrud KI; Beiske AG; Bjerve KS; Hovdal H; Midgard R; Kvistad SS; Holmøy T; Riise T; Torkildsen Ø
    Eur J Neurol; 2016 Jun; 23(6):1064-70. PubMed ID: 26998820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of HLA-DRB1 alleles on susceptibility and outcome of a Portuguese Multiple Sclerosis population.
    Silva AM; Pereira C; Bettencourt A; Carvalho C; Couto AR; Leite MI; Marta M; Freijo M; Costa PP; Mendonça D; Monteiro L; Armas JB; Martins B
    J Neurol Sci; 2007 Jul; 258(1-2):69-74. PubMed ID: 17412364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of cerebrospinal-fluid oligoclonal immunoglobulin bands and HLA-DRB1 risk alleles on brain magnetic-resonance-imaging lesion load in Swedish multiple sclerosis patients.
    Karrenbauer VD; Prejs R; Masterman T; Hillert J; Glaser A; Imrell K
    J Neuroimmunol; 2013 Jan; 254(1-2):170-3. PubMed ID: 22967351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Parent-of-origin of HLA-DRB1*1501 and age of onset of multiple sclerosis.
    Ramagopalan SV; Byrnes JK; Dyment DA; Guimond C; Handunnetthi L; Disanto G; Yee IM; Ebers GC; Sadovnick AD
    J Hum Genet; 2009 Sep; 54(9):547-9. PubMed ID: 19629136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epstein-Barr virus and multiple sclerosis: interaction with HLA.
    Sundqvist E; Sundström P; Lindén M; Hedström AK; Aloisi F; Hillert J; Kockum I; Alfredsson L; Olsson T
    Genes Immun; 2012 Jan; 13(1):14-20. PubMed ID: 21776012
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A meta-analysis of interaction between Epstein-Barr virus and HLA-DRB1*1501 on risk of multiple sclerosis.
    Xiao D; Ye X; Zhang N; Ou M; Guo C; Zhang B; Liu Y; Wang M; Yang G; Jing C
    Sci Rep; 2015 Dec; 5():18083. PubMed ID: 26656273
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A long-term follow-up study using IPMSSG criteria in children with CNS demyelination.
    Peche SS; Alshekhlee A; Kelly J; Lenox J; Mar S
    Pediatr Neurol; 2013 Nov; 49(5):329-34. PubMed ID: 23993834
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Response to 'Seasonal variation of vitamin D and Epstein-Barr virus antibody in multiple sclerosis patients', a comment letter regarding 'Vitamin D, HLA-DRB1 and Epstein-Barr virus antibody levels in a prospective cohort of multiple sclerosis patients'.
    Wergeland S; Riise T; Torkildsen Ø
    Eur J Neurol; 2018 Sep; 25(9):e104. PubMed ID: 30134049
    [No Abstract]   [Full Text] [Related]  

  • 38. Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study.
    Kuhle J; Disanto G; Dobson R; Adiutori R; Bianchi L; Topping J; Bestwick JP; Meier UC; Marta M; Dalla Costa G; Runia T; Evdoshenko E; Lazareva N; Thouvenot E; Iaffaldano P; Direnzo V; Khademi M; Piehl F; Comabella M; Sombekke M; Killestein J; Hegen H; Rauch S; D'Alfonso S; Alvarez-Cermeño JC; Kleinová P; Horáková D; Roesler R; Lauda F; Llufriu S; Avsar T; Uygunoglu U; Altintas A; Saip S; Menge T; Rajda C; Bergamaschi R; Moll N; Khalil M; Marignier R; Dujmovic I; Larsson H; Malmestrom C; Scarpini E; Fenoglio C; Wergeland S; Laroni A; Annibali V; Romano S; Martínez AD; Carra A; Salvetti M; Uccelli A; Torkildsen Ø; Myhr KM; Galimberti D; Rejdak K; Lycke J; Frederiksen JL; Drulovic J; Confavreux C; Brassat D; Enzinger C; Fuchs S; Bosca I; Pelletier J; Picard C; Colombo E; Franciotta D; Derfuss T; Lindberg R; Yaldizli Ö; Vécsei L; Kieseier BC; Hartung HP; Villoslada P; Siva A; Saiz A; Tumani H; Havrdová E; Villar LM; Leone M; Barizzone N; Deisenhammer F; Teunissen C; Montalban X; Tintoré M; Olsson T; Trojano M; Lehmann S; Castelnovo G; Lapin S; Hintzen R; Kappos L; Furlan R; Martinelli V; Comi G; Ramagopalan SV; Giovannoni G
    Mult Scler; 2015 Jul; 21(8):1013-24. PubMed ID: 25680984
    [TBL] [Abstract][Full Text] [Related]  

  • 39. No evidence for an effect of DNA methylation on multiple sclerosis severity at HLA-DRB1*15 or HLA-DRB5.
    Handel AE; De Luca GC; Morahan J; Handunnetthi L; Sadovnick AD; Ebers GC; Ramagopalan SV
    J Neuroimmunol; 2010 Jun; 223(1-2):120-3. PubMed ID: 20394989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Defining high, medium and low impact prognostic factors for developing multiple sclerosis.
    Tintore M; Rovira À; Río J; Otero-Romero S; Arrambide G; Tur C; Comabella M; Nos C; Arévalo MJ; Negrotto L; Galán I; Vidal-Jordana A; Castilló J; Palavra F; Simon E; Mitjana R; Auger C; Sastre-Garriga J; Montalban X
    Brain; 2015 Jul; 138(Pt 7):1863-74. PubMed ID: 25902415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.